Enhanced prefrontal nicotinic signaling as evidence of active compensation in Alzheimer's disease models

SK Power, S Venkatesan, S Qu, JA McLaurin… - bioRxiv, 2023 - biorxiv.org
Background: Cognitive reserve allows for active compensation during neuropathology.
Here, we examine electrophysiological evidence for active compensation in Alzheimer's …

Cholinergic reinforcement signaling is impaired by amyloidosis prior to its synaptic loss

S Allard, MGH Shuler - Journal of Neuroscience, 2023 - Soc Neuroscience
Alzheimer's disease (AD) is associated with amyloidosis and dysfunction of the cholinergic
system, which is crucial for learning and memory. However, the nature of acetylcholine …

Impaired neuromodulator crosstalk delays vigilance-dependent astroglia Ca2+ activation in mouse models of Alzheimer's disease

EY Lim, A Salinas, L Ye, Y Yang, M Paukert - bioRxiv, 2022 - biorxiv.org
Degeneration in neuronal nuclei producing the neuromodulators acetylcholine and
norepinephrine is a hallmark of Alzheimer's disease (AD). Therapeutic interventions that …

Nucleus Basalis Stimulation Enhances Working Memory by Stabilizing Attractor Networks in Prefrontal Cortex

XL Qi, R Liu, B Singh, D Bestue, A Compte… - bioRxiv, 2019 - biorxiv.org
Acetylcholine in the neocortex is critical for executive function. Degeneration of the basal
forebrain cholinergic system is associated with cognitive decline in aging and Alzheimer's …

Impaired cholinergic excitation of prefrontal attention circuitry in the TgCRND8 model of Alzheimer's disease

É Proulx, P Fraser, JA McLaurin… - Journal of …, 2015 - Soc Neuroscience
Attention deficits in Alzheimer's disease can exacerbate its other cognitive symptoms, yet
relevant disruptions of key prefrontal circuitry are not well understood. Here, in the …

New perspectives on the basal forebrain cholinergic system in Alzheimer's disease

AS Berry, TM Harrison - Neuroscience & Biobehavioral Reviews, 2023 - Elsevier
The basal forebrain cholinergic system (BFCS) has long been implicated in age-related
cognitive changes and the pathophysiology of Alzheimer's disease (AD). Limitations of …

Steps towards developing effective treatments for neuropsychiatric disturbances in Alzheimer's disease: Insights from preclinical models, clinical data, and future …

A Clement, O Wiborg, AA Asuni - Frontiers in Aging Neuroscience, 2020 - frontiersin.org
Alzheimer's disease (AD) is the most common form of dementia worldwide. It is mostly
known for its devastating effect on memory and learning but behavioral alterations …

[HTML][HTML] Posterior cingulate cortex network predicts Alzheimer's disease progression

PL Lee, KH Chou, CP Chung, TH Lai… - Frontiers in aging …, 2020 - frontiersin.org
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the
accumulation of toxic misfolded proteins, which are believed to have propagated from …

Apamin improves prefrontal nicotinic impairment in mouse model of Alzheimer's disease

É Proulx, SK Power, DK Oliver, D Sargin… - Cerebral …, 2020 - academic.oup.com
Disruption of attention is an early and disabling symptom of Alzheimer's disease (AD). The
underlying cellular mechanisms are poorly understood and treatment options for patients …

Is bigger better? Towards a mechanistic understanding of neuropsychiatric symptoms in Alzheimer's disease

MA Nowrangi, PB Rosenberg - International psychogeriatrics, 2021 - cambridge.org
It is increasingly clear that the public health burden of Alzheimer's disease (AD) is not solely
due to cognitive decline but also to neuropsychiatric symptoms (NPS). NPS such as …